Diagnostic delay of malignant melanoma due to the corona-pandemic

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030310

Enrollment

2800

Registered

2023-01-10

Start date

2019-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43.9

Interventions

Group 1: Monocentric, non-interventional, open, retrospective study. The data set is to be collected from the tumor documentation of the skin tumor center in Nuremberg Group 2: the tumor specific data

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all patients of the skincancer-center Nuerenberg that with the diagnose of malignant melanoma in the years 2012 until march 2021

Exclusion criteria

Exclusion criteria: patients who are diganosed with two or more malignant melanoma were excluded

Design outcomes

Primary

Measure	Time frame
tumor thickness	—

Secondary

Measure	Time frame
AJCC, ICD-10, gender, ulceration, questionnaire for qualitative characteristics (possible reasons for a delay in diagnosis), date of the initial diagnosis	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026